Lenvatinib for thymic carcinomas

Lancet Oncol. 2020 Jun;21(6):745-746. doi: 10.1016/S1470-2045(20)30213-8.

Authors

Nobuyuki Takahashi¹, Anish Thomas²

Affiliations

¹ Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
² Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA. Electronic address: anish.thomas@nih.gov.

PMID: 32502438
DOI: 10.1016/S1470-2045(20)30213-8

No abstract available

MeSH terms

Humans
Phenylurea Compounds
Quinolines*
Thymoma*
Thymus Neoplasms*

Substances

Phenylurea Compounds
Quinolines
lenvatinib